CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Loading researcher profile…

Anonymous aggregate analytics use the connection IP transiently only to derive country; the IP is not stored in analytics data. DNT and GPC are honored, with 90-day retention. IP Geolocation by DB-IP.

CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Researchers/Profile

Researcher profile

Emilie Jouanjus

OPENALEX: A5086216228↗ORCID: 0000-0002-3510-2475↗

Affiliations

Organizations

Centre de Recherches en Cancérologie de Toulouseauthorship · FR Centre Hospitalier Universitaire de Montpellierauthorship · FR Insermauthorship · FR Laboratoire Epidémiologie et Analyses en Santé Publique : Risques, Maladies Chroniques et Handicapsauthorship · FR Mercer Universityauthorship · US Pharmacochimie et Biologie pour le Développementauthorship · FR Université de Montpellierauthorship · FR Université Fédérale de Toulouse Midi-Pyrénéesauthorship · FR Université Toulouse III - Paul Sabatierauthorship · FR

Public evidence

4 connected articles

Cannabis and Cannabinoid-Related Suspected Adverse Drug Reactions: Global Patterns and Cross-National Analysis Based on VigiBase® Data2026 · PubMed Central Open Access Cannabinoids and Adverse Convulsive Effects: A Pharmacovigilance and Addictovigilance Analysis of Cases Reported in France.2025 · Europe PMC Adverse events of recreational cannabis use during pregnancy reported to the French Addictovigilance Network between 2011 and 2020.2022 · Europe PMC Cannabis Use: Signal of Increasing Risk of Serious Cardiovascular Disorders2014 · PubMed Central Open Access

Matched by exact identifiers only. Profile data: ORCID. Last retrieved 09/09/2026.

Emilie Jouanjus - Medical Cannabis Research Engine